Core Insights - Cortechs.ai and EDAP TMS SA have successfully completed the world's first OnQ Prostate-assisted Focal One® Robotic HIFU procedure, marking a significant milestone in prostate cancer care [1][6] - OnQ Prostate's patented RSI technology enhances lesion localization and targeting, providing urologists with more detailed information for patient selection and treatment planning [2][6] Company Developments - Cortechs.ai is positioned as a leader in AI applications in radiology, focusing on advanced imaging technologies to improve disease screening and early detection, particularly in prostate cancer [5] - EDAP TMS SA is recognized for its innovative robotic energy-based therapies, with the Focal One platform being a leading solution for prostate focal therapy [8] Clinical Impact - The integration of OnQ Prostate with Focal One Robotic HIFU is expected to improve the precision and personalization of prostate cancer treatments, potentially leading to better patient outcomes [3][4] - The successful application of OnQ Prostate technology at UCSF demonstrates its capability to enhance the standardization of prostate MRI interpretation, which is crucial for effective treatment [3][6]
Cortechs.ai and EDAP Announce World's First OnQ™ Prostate-Assisted Focal One® Robotic HIFU Procedure at UCSF Prostate Cancer Center